N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide

C103H104N42O7S5 — CID 159321659

IUPACN-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
SMILESCNC1CCC(Nc2ccc3nnc(Sc4ccc5nc(NC(=O)C6CC6)cn5n4)n3c2)C1.O=C(Nc1cn2nc(Sc3nnc4ccc(N5CCNCC5)cn34)ccc2n1)C1CC1.O=C(Nc1cn2nc(Sc3nnc4ccc(NC5CCCC5)cn34)ccc2n1)C1CC1.O=C(Nc1cn2nc(Sc3nnc4ccc(NC5CCOC5)cn34)ccc2n1)C1CC1.O=C(Nc1cn2nc(Sc3nnc4ccc(Nc5ccco5)cn34)ccc2n1)C1CC1
InChIInChI=1S/C22H25N9OS.C21H22N8OS.C20H21N9OS.C20H20N8O2S.C20H16N8O2S/c1-23-14-4-5-15(10-14)24-16-6-7-19-27-28-22(30(19)11-16)33-20-9-8-18-25-17(12-31(18)29-20)26-21(32)13-2-3-13;30-20(13-5-6-13)24-16-12-29-17(23-16)9-10-19(27-29)31-21-26-25-18-8-7-15(11-28(18)21)22-14-3-1-2-4-14;30-19(13-1-2-13)23-15-12-29-16(22-15)5-6-18(26-29)31-20-25-24-17-4-3-14(11-28(17)20)27-9-7-21-8-10-27;29-19(12-1-2-12)23-15-10-28-16(22-15)5-6-18(26-28)31-20-25-24-17-4-3-13(9-27(17)20)21-14-7-8-30-11-14;29-19(12-3-4-12)23-14-11-28-15(22-14)7-8-18(26-28)31-20-25-24-16-6-5-13(10-27(16)20)21-17-2-1-9-30-17/h6-9,11-15,23-24H,2-5,10H2,1H3,(H,26,32);7-14,22H,1-6H2,(H,24,30);3-6,11-13,21H,1-2,7-10H2,(H,23,30);3-6,9-10,12,14,21H,1-2,7-8,11H2,(H,23,29);1-2,5-12,21H,3-4H2,(H,23,29)
InChIKeyLDVPBSTYTKDVSY-UHFFFAOYSA-N
MW2202.59 g/mol
LogP14.21
Rot. Bonds30

About N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide

N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide (PubChem CID 159321659) has the molecular formula C103H104N42O7S5 and a molecular weight of 2202.59 g/mol. Its IUPAC name is N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide.

Molecular Properties

Compound NameN-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
PubChem CID159321659
Molecular FormulaC103H104N42O7S5
Molecular Weight2202.59 g/mol
Exact Mass2200.77
IUPAC NameN-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
SMILESCNC1CCC(Nc2ccc3nnc(Sc4ccc5nc(NC(=O)C6CC6)cn5n4)n3c2)C1.O=C(Nc1cn2nc(Sc3nnc4ccc(N5CCNCC5)cn34)ccc2n1)C1CC1.O=C(Nc1cn2nc(Sc3nnc4ccc(NC5CCCC5)cn34)ccc2n1)C1CC1.O=C(Nc1cn2nc(Sc3nnc4ccc(NC5CCOC5)cn34)ccc2n1)C1CC1.O=C(Nc1cn2nc(Sc3nnc4ccc(Nc5ccco5)cn34)ccc2n1)C1CC1
InChIInChI=1S/C22H25N9OS.C21H22N8OS.C20H21N9OS.C20H20N8O2S.C20H16N8O2S/c1-23-14-4-5-15(10-14)24-16-6-7-19-27-28-22(30(19)11-16)33-20-9-8-18-25-17(12-31(18)29-20)26-21(32)13-2-3-13;30-20(13-5-6-13)24-16-12-29-17(23-16)9-10-19(27-29)31-21-26-25-18-8-7-15(11-28(18)21)22-14-3-1-2-4-14;30-19(13-1-2-13)23-15-12-29-16(22-15)5-6-18(26-29)31-20-25-24-17-4-3-14(11-28(17)20)27-9-7-21-8-10-27;29-19(12-1-2-12)23-15-10-28-16(22-15)5-6-18(26-28)31-20-25-24-17-4-3-13(9-27(17)20)21-14-7-8-30-11-14;29-19(12-3-4-12)23-14-11-28-15(22-14)7-8-18(26-28)31-20-25-24-16-6-5-13(10-27(16)20)21-17-2-1-9-30-17/h6-9,11-15,23-24H,2-5,10H2,1H3,(H,26,32);7-14,22H,1-6H2,(H,24,30);3-6,11-13,21H,1-2,7-10H2,(H,23,30);3-6,9-10,12,14,21H,1-2,7-8,11H2,(H,23,29);1-2,5-12,21H,3-4H2,(H,23,29)
InChIKeyLDVPBSTYTKDVSY-UHFFFAOYSA-N
XLogP14.21
TPSA545.19 Ų
H-Bond Donors11
H-Bond Acceptors49
Rotatable Bonds30
Heavy Atoms157
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002202.59
LogP ≤ 514.21
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1049

Analyze N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
CID 59233081
N-[6-[[6-(dimethylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-ethoxy-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-morpholin-4-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(propan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-propan-2-yloxy-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
CID 157197768

Frequently Asked Questions

What is the IUPAC name of N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide?
The IUPAC name of N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide (CID 159321659) is N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide.
What is the SMILES notation for N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide?
The canonical SMILES for N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide is CNC1CCC(Nc2ccc3nnc(Sc4ccc5nc(NC(=O)C6CC6)cn5n4)n3c2)C1.O=C(Nc1cn2nc(Sc3nnc4ccc(N5CCNCC5)cn34)ccc2n1)C1CC1.O=C(Nc1cn2nc(Sc3nnc4ccc(NC5CCCC5)cn34)ccc2n1)C1CC1.O=C(Nc1cn2nc(Sc3nnc4ccc(NC5CCOC5)cn34)ccc2n1)C1CC1.O=C(Nc1cn2nc(Sc3nnc4ccc(Nc5ccco5)cn34)ccc2n1)C1CC1.
What is the InChIKey of N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide?
The InChIKey is LDVPBSTYTKDVSY-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H25N9OS.C21H22N8OS.C20H21N9OS.C20H20N8O2S.C20H16N8O2S/c1-23-14-4-5-15(10-14)24-16-6-7-19-27-28-22(30(19)11-16)33-20-9-8-18-25-17(12-31(18)29-20)26-21(32)13-2-3-13;30-20(13-5-6-13)24-16-12-29-17(23-16)9-10-19(27-29)31-21-26-25-18-8-7-15(11-28(18)21)22-14-3-1-2-4-14;30-19(13-1-2-13)23-15-12-29-16(22-15)5-6-18(26-29)31-20-25-24-17-4-3-14(11-28(17)20)27-9-7-21-8-10-27;29-19(12-1-2-12)23-15-10-28-16(22-15)5-6-18(26-28)31-20-25-24-17-4-3-13(9-27(17)20)21-14-7-8-30-11-14;29-19(12-3-4-12)23-14-11-28-15(22-14)7-8-18(26-28)31-20-25-24-16-6-5-13(10-27(16)20)21-17-2-1-9-30-17/h6-9,11-15,23-24H,2-5,10H2,1H3,(H,26,32);7-14,22H,1-6H2,(H,24,30);3-6,11-13,21H,1-2,7-10H2,(H,23,30);3-6,9-10,12,14,21H,1-2,7-8,11H2,(H,23,29);1-2,5-12,21H,3-4H2,(H,23,29).
What are the key properties of N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide?
N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide has a molecular weight of 2202.59 g/mol, XLogP of 14.21, 30 rotatable bonds, 11 hydrogen bond donors, and 49 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-[[6-(cyclopentylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(furan-2-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-[[3-(methylamino)cyclopentyl]amino]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(oxolan-3-ylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[(6-piperazin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide is sourced from PubChem (CID 159321659), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).